首页 > 最新文献

Acta Medica Mediterranea最新文献

英文 中文
Unusual Presentation of Follicular Lymphoma with the Involvement of Bilateral Ear Helices and Lobes 少见的滤泡性淋巴瘤累及双耳螺旋和耳垂
IF 0.3 4区 医学 Q4 Medicine Pub Date : 2022-06-13 DOI: 10.32552/2022.actamedica.736
Ecem Bostan, A. Karaduman, Ece Özoğul, S. Akın
Follicular lymphoma is a type of systemic lymphomas which constitutes approximately 30-35% of all Non-Hodgkin lymphomas. It typically presents itself in the form of generalized lymphadenopathy, hepatomegaly, splenomegaly and bone marrow involvement. Cutaneous involvement of follicular lymphoma generally appears as skin-coloured to red, violaceous papules or nodules most commonly involving the scalp, trunk and head&neck region. Herein, we would like to present an unusual case of follicular lymphoma which appears as skin-coloured papules prominent upon the both ears and trunk.
滤泡性淋巴瘤是一种全身性淋巴瘤,约占所有非霍奇金淋巴瘤的30-35%。典型表现为全身性淋巴结病、肝肿大、脾肿大和骨髓受累。滤泡性淋巴瘤的皮肤受累通常表现为皮肤颜色到红色,紫色丘疹或结节,最常累及头皮,躯干和头颈部。在此,我们要报告一个不寻常的滤泡性淋巴瘤病例,表现为双耳和躯干上突出的皮肤颜色丘疹。
{"title":"Unusual Presentation of Follicular Lymphoma with the Involvement of Bilateral Ear Helices and Lobes","authors":"Ecem Bostan, A. Karaduman, Ece Özoğul, S. Akın","doi":"10.32552/2022.actamedica.736","DOIUrl":"https://doi.org/10.32552/2022.actamedica.736","url":null,"abstract":"Follicular lymphoma is a type of systemic lymphomas which constitutes approximately 30-35% of all Non-Hodgkin lymphomas. It typically presents itself in the form of generalized lymphadenopathy, hepatomegaly, splenomegaly and bone marrow involvement. Cutaneous involvement of follicular lymphoma generally appears as skin-coloured to red, violaceous papules or nodules most commonly involving the scalp, trunk and head&neck region. Herein, we would like to present an unusual case of follicular lymphoma which appears as skin-coloured papules prominent upon the both ears and trunk.","PeriodicalId":50891,"journal":{"name":"Acta Medica Mediterranea","volume":"33 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84280361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of Mean Platelet Volume as a Prognostic Criterion in Non-Healing Wounds 平均血小板体积作为未愈合伤口预后标准的研究
IF 0.3 4区 医学 Q4 Medicine Pub Date : 2022-03-19 DOI: 10.32552/2022.actamedica.673
F. Tutak, F. Doğan, Aşkı Vural
Objective: We aimed to evaluate if the Mean Platelet Volume (MPV) is an acute phase reactant in non-healing wounds, by analyzing its correlation with Erythrocyte Sedimentation Rate (ESR). Method: Our study was carried out in a descriptive type with the participation of patients with non-healing wounds. The laboratory data and characteristics of the patients were accessed retrospectively, and the obtained data were recorded in the data recording form. Results: The sample group consisted of 92 patients with non-healing wounds. 26.9% of the patients with non-healing wounds had pressure sores, 37.6% of them had diabetic foot wounds, 18.3% had non-healing wounds developed after trauma, and 17.2% had necrotizing fasciitis. The average age of the patients was 53.22±19.13, and the average length of stay in the hospital was 108.98±18.78 (min 3 months, max 6 months) days. The MPV value, which was found to be high in the early stages of non-healing wounds, decreased after the wound was completely healed. When the MPV value was compared to ESR, an acute phase reactant, a positive and strong statistically significant correlation was found between MPV and ESR based on the result of this correlation analysis (r=0.256, p<0.01). Conclusion: MPV can be used as a marker, just like ESR, in the presence of non-healing wounds. MPV value can be measured with blood taken into the complete blood count. However, an extra blood sample and a different tube are required for ESR. Using MPV value instead of ESR will provide savings in terms of cost and labor.
目的:通过分析平均血小板体积(MPV)与红细胞沉降率(ESR)的相关性,探讨MPV是否为未愈合伤口的急性期反应物。方法:我们的研究以描述性的方式进行,有未愈合伤口的患者参与。回顾性查阅患者的实验室资料及特点,并将所得资料记录在资料记录表中。结果:样本组为92例未愈合伤口患者。26.9%的患者有压疮,37.6%的患者有糖尿病足外伤,18.3%的患者外伤后出现不愈合,17.2%的患者有坏死性筋膜炎。患者平均年龄53.22±19.13岁,平均住院时间108.98±18.78天(最小3个月,最大6个月)。未愈合创面早期MPV值较高,创面完全愈合后MPV值下降。将MPV值与急性期反应物ESR值进行比较,相关分析结果显示MPV值与ESR值呈显著正相关(r=0.256, p<0.01)。结论:MPV与ESR一样,可作为未愈合伤口的标志物。MPV值可以通过取血进入全血细胞计数来测量。然而,ESR需要额外的血液样本和不同的试管。使用MPV值代替ESR值可以节省成本和人力。
{"title":"Investigation of Mean Platelet Volume as a Prognostic Criterion in Non-Healing Wounds","authors":"F. Tutak, F. Doğan, Aşkı Vural","doi":"10.32552/2022.actamedica.673","DOIUrl":"https://doi.org/10.32552/2022.actamedica.673","url":null,"abstract":"Objective: We aimed to evaluate if the Mean Platelet Volume (MPV) is an acute phase reactant in non-healing wounds, by analyzing its correlation with Erythrocyte Sedimentation Rate (ESR). \u0000Method: Our study was carried out in a descriptive type with the participation of patients with non-healing wounds. The laboratory data and characteristics of the patients were accessed retrospectively, and the obtained data were recorded in the data recording form. \u0000Results: The sample group consisted of 92 patients with non-healing wounds. 26.9% of the patients with non-healing wounds had pressure sores, 37.6% of them had diabetic foot wounds, 18.3% had non-healing wounds developed after trauma, and 17.2% had necrotizing fasciitis. The average age of the patients was 53.22±19.13, and the average length of stay in the hospital was 108.98±18.78 (min 3 months, max 6 months) days. The MPV value, which was found to be high in the early stages of non-healing wounds, decreased after the wound was completely healed. When the MPV value was compared to ESR, an acute phase reactant, a positive and strong statistically significant correlation was found between MPV and ESR based on the result of this correlation analysis (r=0.256, p<0.01). \u0000Conclusion: MPV can be used as a marker, just like ESR, in the presence of non-healing wounds. MPV value can be measured with blood taken into the complete blood count. However, an extra blood sample and a different tube are required for ESR. Using MPV value instead of ESR will provide savings in terms of cost and labor.","PeriodicalId":50891,"journal":{"name":"Acta Medica Mediterranea","volume":"8 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72524002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Relationship Between ST-Segment Depression in Lead aVR and Coronary Microvascular Function in Acute Inferior Myocardial Infarction 急性下壁心肌梗死导联aVR st段下降与冠状动脉微血管功能的关系
IF 0.3 4区 医学 Q4 Medicine Pub Date : 2022-03-17 DOI: 10.32552/2022.actamedica.681
B. Aslan, M. Karahan
Aim: The aim of this study was to investigate the relationship between ST-segment depression in the aVR lead and coronary microvascular function in acute inferior myocardial infarction undergoing primary percutaneous intervention. Methods:  287 patients with inferior myocardial infarction confirmed by coronary angiography were divided into two groups with and without ST-segment depression in lead aVR  ≥ 0.1 mV on the 12 lead ECG. Electrocardiographic recordings were made for the evaluation of ST-segment resolution before and after primary PCI. Angiographic assessment in the infarct-related artery was performed by using the myocardial blush grade and thrombolysis in myocardial infarction flow.   Results: Overall, 51 of 287 patients had ST-segment depression in lead aVR. The number of patients with RCA-induced infarction was higher in the group with ST-segment depression in lead aVR. RCA involvement was present in 44 patients. Peak troponin was higher in the group with ST-segment depression in lead aVR compare to the other group (P <0.001). The MBG was more impaired, and the STR was less regressed in patients with ST depression in lead aVR  (p<0,001). The ejection fraction of patients with ST-segment depression in lead aVR was lower. Conclusion: We found that ST-segment depression in lead aVR was associated with impaired myocardial perfusion in patients with inferior myocardial infarction.
目的:探讨经皮介入治疗急性下壁心肌梗死患者aVR导联st段下降与冠状动脉微血管功能的关系。方法:287例经冠状动脉造影证实的下段心肌梗死患者分为12导联心电图aVR≥0.1 mV伴有st段降导联和未伴有st段降导联两组。进行心电图记录,评价首次PCI术前和术后st段分辨率。通过心肌红晕分级和心肌梗死血流溶栓对梗死相关动脉进行血管造影评估。结果:总体而言,287例患者中有51例aVR导联st段下降。aVR导联st段下降组rca诱发的梗死患者数量较多。44例患者有RCA受累。aVR导联st段下降组肌钙蛋白峰值高于其他组(P <0.001)。aVR导联中ST抑制患者MBG受损更严重,STR退化更少(p< 0.001)。aVR导联st段下降患者的射血分数较低。结论:我们发现aVR导联st段下降与下壁心肌梗死患者心肌灌注受损有关。
{"title":"The Relationship Between ST-Segment Depression in Lead aVR and Coronary Microvascular Function in Acute Inferior Myocardial Infarction","authors":"B. Aslan, M. Karahan","doi":"10.32552/2022.actamedica.681","DOIUrl":"https://doi.org/10.32552/2022.actamedica.681","url":null,"abstract":"Aim: The aim of this study was to investigate the relationship between ST-segment depression in the aVR lead and coronary microvascular function in acute inferior myocardial infarction undergoing primary percutaneous intervention. \u0000Methods:  287 patients with inferior myocardial infarction confirmed by coronary angiography were divided into two groups with and without ST-segment depression in lead aVR  ≥ 0.1 mV on the 12 lead ECG. Electrocardiographic recordings were made for the evaluation of ST-segment resolution before and after primary PCI. Angiographic assessment in the infarct-related artery was performed by using the myocardial blush grade and thrombolysis in myocardial infarction flow.   \u0000Results: Overall, 51 of 287 patients had ST-segment depression in lead aVR. The number of patients with RCA-induced infarction was higher in the group with ST-segment depression in lead aVR. RCA involvement was present in 44 patients. Peak troponin was higher in the group with ST-segment depression in lead aVR compare to the other group (P <0.001). The MBG was more impaired, and the STR was less regressed in patients with ST depression in lead aVR  (p<0,001). The ejection fraction of patients with ST-segment depression in lead aVR was lower. \u0000Conclusion: We found that ST-segment depression in lead aVR was associated with impaired myocardial perfusion in patients with inferior myocardial infarction.","PeriodicalId":50891,"journal":{"name":"Acta Medica Mediterranea","volume":"500 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90251672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Clinical Profiles, Angiographic Features and Outcomes of Young and Elderly Patients with ST-Segment Elevation Myocardial Infarction 青壮年与老年st段抬高型心肌梗死的临床特点、血管造影特征及预后比较
IF 0.3 4区 医学 Q4 Medicine Pub Date : 2022-03-17 DOI: 10.32552/2022.actamedica.670
Bektaş Murat, S. Murat
Objective: It is to reveal the differences between clinical, angiographic, in-hospital and one-year follow-up results between young and elderly patients with acute ST-segment elevation myocardial infarction. Material and Methods: This study was designed retrospectively in two centers. 2891 patients were screened; 260 of which were young. 260 elderly patients were randomly selected among the patients and the differences between both groups were evaluated. Results: The median age of the young patients was 37 (34-39) years and the median age of the elderly patients was 65 (56-73) years, and male gender was dominant in both groups. Young patients were more likely to be admitted with Killip class 1, while older patients were more likely to be admitted with Killip class 2 (P=0.002). Single-vessel disease was more common in young patients (81.0% vs. 46.3%; P<0.001), while multi-vessel disease was more common in the elderly patients (19.0% vs. 53.7%; P<0.001). In one-year follow-up, all-cause hospitalization was lower in younger patients, but there was no significant difference in mortality between elderly and young patients. Conclusion: Young patients presenting with ST-segment elevation myocardial infarction were more frequent smokers, obese and dyslipidemic and although in-hospital outcomes were better than the elderly, one-year mortality was similar to those of the elderly.
目的:探讨青年与老年急性st段抬高型心肌梗死患者临床、血管造影、住院及1年随访结果的差异。材料和方法:本研究在两个中心回顾性设计。筛查2891例患者;其中260人是年轻人。在患者中随机抽取260例老年患者,比较两组患者的差异。结果:青年患者中位年龄为37(34 ~ 39)岁,老年患者中位年龄为65(56 ~ 73)岁,两组均以男性为主。年轻患者更容易进入Killip 1级,而老年患者更容易进入Killip 2级(P=0.002)。单血管疾病在年轻患者中更为常见(81.0% vs. 46.3%;P<0.001),而多血管病变在老年患者中更为常见(19.0% vs. 53.7%;P < 0.001)。在一年的随访中,年轻患者的全因住院率较低,但老年和年轻患者的死亡率无显著差异。结论:年轻st段抬高型心肌梗死患者吸烟、肥胖和血脂异常的发生率高于老年患者,虽然住院预后优于老年患者,但一年死亡率与老年患者相似。
{"title":"Comparison of Clinical Profiles, Angiographic Features and Outcomes of Young and Elderly Patients with ST-Segment Elevation Myocardial Infarction","authors":"Bektaş Murat, S. Murat","doi":"10.32552/2022.actamedica.670","DOIUrl":"https://doi.org/10.32552/2022.actamedica.670","url":null,"abstract":"Objective: It is to reveal the differences between clinical, angiographic, in-hospital and one-year follow-up results between young and elderly patients with acute ST-segment elevation myocardial infarction. \u0000Material and Methods: This study was designed retrospectively in two centers. 2891 patients were screened; 260 of which were young. 260 elderly patients were randomly selected among the patients and the differences between both groups were evaluated. \u0000Results: The median age of the young patients was 37 (34-39) years and the median age of the elderly patients was 65 (56-73) years, and male gender was dominant in both groups. Young patients were more likely to be admitted with Killip class 1, while older patients were more likely to be admitted with Killip class 2 (P=0.002). Single-vessel disease was more common in young patients (81.0% vs. 46.3%; P<0.001), while multi-vessel disease was more common in the elderly patients (19.0% vs. 53.7%; P<0.001). In one-year follow-up, all-cause hospitalization was lower in younger patients, but there was no significant difference in mortality between elderly and young patients. \u0000Conclusion: Young patients presenting with ST-segment elevation myocardial infarction were more frequent smokers, obese and dyslipidemic and although in-hospital outcomes were better than the elderly, one-year mortality was similar to those of the elderly.","PeriodicalId":50891,"journal":{"name":"Acta Medica Mediterranea","volume":"4 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79062804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluation of Sleep Quality with Use of Angiotensin Receptor Neprilysin Inhibitor in Patients with Reduced Ejection Fraction Heart Failure 使用血管紧张素受体奈普利素抑制剂评价低射血分数心力衰竭患者的睡眠质量
IF 0.3 4区 医学 Q4 Medicine Pub Date : 2022-03-17 DOI: 10.32552/2022.actamedica.645
F. Işık, M. Okşul, B. Aslan, E. Taştan
Background and Aim: It is known that chronic heart failure reduces sleep quality by causing sleep problems. In recent years, it has been observed that sacubitril-valsartan, which is an angiotensin receptor neprilysin inhibitor, reduces mortality and hospitalization in patients with heart failure. The aim of our study is to examine whether sacubitril-valsartan affects sleep quality in patients with reduced ejection fraction heart failure apart from these benefits. Material and Method: In our study, 44 patients with a history of heart failure with reduced ejection fraction applied to our cardiology outpatient clinic of Gazi Yaşargil Training and Research Hospital were included. Demographic, clinical, laboratory, electrocardiographic, and echocardiographic parameters of these patients were examined. Sacubitril-valsartan treatment was initiated in all patients. Dose titration was performed in patients who could tolerate the treatment. Pittsburgh sleep quality index questionnaire was performed in all patients before treatment and at the end of the second month. Result: The median age of the study population was 61.5 (47.2 - 70.7, IQR) years and 30 (68.2 %) of them were male. There were 30 (72.7 %) ischemic heart failure patients and 14 (27.3 %) non-ischemic heart failure patients. There was a significant decrease in the number of patients with poor sleep quality after angiotensin receptor neprilysin inhibitor treatment compared to baseline [36 (81.8 %) vs 30 (68.2 %), p= 0.031]. In addition, there was a significant decrease in the total Pittsburgh sleep quality index score of patients compared to the baseline [9.0 (7.0 - 12.0) vs 7.0 (5.0 - 9.0), p < 0.001]. Conclusion: In our study, we observed that sacubitril-valsartan treatment improves sleep quality in patients with reduced ejection fraction heart failure.
背景和目的:众所周知,慢性心力衰竭会导致睡眠问题,从而降低睡眠质量。近年来有研究发现,血管紧张素受体奈普利素抑制剂苏比替-缬沙坦可降低心力衰竭患者的死亡率和住院率。我们研究的目的是检查除了这些益处外,苏比替-缬沙坦是否会影响射血分数降低的心力衰竭患者的睡眠质量。材料与方法:选取Gazi ya argil培训研究医院心内科门诊44例有心力衰竭伴射血分数降低的患者作为研究对象。对这些患者的人口学、临床、实验室、心电图和超声心动图参数进行了检查。所有患者均开始使用沙比替-缬沙坦治疗。对耐受治疗的患者进行剂量滴定。所有患者在治疗前及治疗后第二个月末分别进行匹兹堡睡眠质量指数问卷调查。结果:研究人群年龄中位数为61.5 (47.2 ~ 70.7,IQR)岁,其中男性30例(68.2%)。缺血性心力衰竭30例(72.7%),非缺血性心力衰竭14例(27.3%)。与基线相比,血管紧张素受体奈普利素抑制剂治疗后睡眠质量差的患者数量显著减少[36例(81.8%)vs 30例(68.2%),p= 0.031]。此外,与基线相比,患者的匹兹堡睡眠质量指数总分显著下降[9.0 (7.0 - 12.0)vs 7.0 (5.0 - 9.0), p < 0.001]。结论:在我们的研究中,我们观察到苏比替-缬沙坦治疗可改善射血分数降低的心力衰竭患者的睡眠质量。
{"title":"Evaluation of Sleep Quality with Use of Angiotensin Receptor Neprilysin Inhibitor in Patients with Reduced Ejection Fraction Heart Failure","authors":"F. Işık, M. Okşul, B. Aslan, E. Taştan","doi":"10.32552/2022.actamedica.645","DOIUrl":"https://doi.org/10.32552/2022.actamedica.645","url":null,"abstract":"Background and Aim: It is known that chronic heart failure reduces sleep quality by causing sleep problems. In recent years, it has been observed that sacubitril-valsartan, which is an angiotensin receptor neprilysin inhibitor, reduces mortality and hospitalization in patients with heart failure. The aim of our study is to examine whether sacubitril-valsartan affects sleep quality in patients with reduced ejection fraction heart failure apart from these benefits. \u0000Material and Method: In our study, 44 patients with a history of heart failure with reduced ejection fraction applied to our cardiology outpatient clinic of Gazi Yaşargil Training and Research Hospital were included. Demographic, clinical, laboratory, electrocardiographic, and echocardiographic parameters of these patients were examined. Sacubitril-valsartan treatment was initiated in all patients. Dose titration was performed in patients who could tolerate the treatment. Pittsburgh sleep quality index questionnaire was performed in all patients before treatment and at the end of the second month. \u0000Result: The median age of the study population was 61.5 (47.2 - 70.7, IQR) years and 30 (68.2 %) of them were male. There were 30 (72.7 %) ischemic heart failure patients and 14 (27.3 %) non-ischemic heart failure patients. There was a significant decrease in the number of patients with poor sleep quality after angiotensin receptor neprilysin inhibitor treatment compared to baseline [36 (81.8 %) vs 30 (68.2 %), p= 0.031]. In addition, there was a significant decrease in the total Pittsburgh sleep quality index score of patients compared to the baseline [9.0 (7.0 - 12.0) vs 7.0 (5.0 - 9.0), p < 0.001]. \u0000Conclusion: In our study, we observed that sacubitril-valsartan treatment improves sleep quality in patients with reduced ejection fraction heart failure.","PeriodicalId":50891,"journal":{"name":"Acta Medica Mediterranea","volume":"70 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89732489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dyspnea and Dysphagia as First Sign of Hypopharyngoesophageal Lipoma 呼吸困难和吞咽困难是下咽食管脂肪瘤的首要征象
IF 0.3 4区 医学 Q4 Medicine Pub Date : 2022-03-17 DOI: 10.32552/2022.actamedica.591
Monika Adásková, K. Obtulovičová, M. Sičák
We present a rare case of a 72-years old male with a big lesion coming out from his mouth suddenly. Examination showed a mucosal lesion seen outside of the mouth, saliva running outside, he was not able to swallow, it was hard to speak and breathe for him. At the time of arrival the patient was stable, later developed a distress and dyspnoe because of the part of tumor inside of his mouth was moving in and out on breathing and was obstructing his airway. This situation required an urgent tracheostomy to secure the patient’s airway. After tracheostomy we continued with endaural approach technique to remove the tumor, the origin of lesion was identified within the postcricoid area. Lesion was removed safely, sent to histology with no complication after. Results came back as a lipoma pedunculated. Literature search did not reveal any cases of limb lipoma presenting with a sudden hanging tumor causing airway compromise and dysphagia, all cases were diagnosed during routine examination. Our case has proven that hypopharyngoesophageal lipoma can present as an acute condition and we have to be able to save and manage patients like this.
我们提出一个罕见的病例,一个大病变突然从他的嘴里出来的72岁男性。检查显示口腔外粘膜病变,唾液流出,他无法吞咽,说话和呼吸困难。患者入院时病情稳定,后来因口中部分肿瘤在呼吸时进进出出,阻塞气道,出现窘迫和呼吸困难。这种情况需要紧急气管切开术来保护患者的气道。气管切开术后,我们继续采用硬膜入路技术切除肿瘤,病变的起源在环后区域被确定。安全切除病灶,送往组织学检查,术后无并发症。结果是带梗的脂肪瘤。文献检索未见肢体脂肪瘤表现为突发性悬垂性肿瘤导致气道损害和吞咽困难,所有病例均在常规检查中诊断。我们的病例已经证明下咽食管脂肪瘤可以作为一种急性疾病出现我们必须能够挽救和治疗这样的病人。
{"title":"Dyspnea and Dysphagia as First Sign of Hypopharyngoesophageal Lipoma","authors":"Monika Adásková, K. Obtulovičová, M. Sičák","doi":"10.32552/2022.actamedica.591","DOIUrl":"https://doi.org/10.32552/2022.actamedica.591","url":null,"abstract":"We present a rare case of a 72-years old male with a big lesion coming out from his mouth suddenly. Examination showed a mucosal lesion seen outside of the mouth, saliva running outside, he was not able to swallow, it was hard to speak and breathe for him. At the time of arrival the patient was stable, later developed a distress and dyspnoe because of the part of tumor inside of his mouth was moving in and out on breathing and was obstructing his airway. This situation required an urgent tracheostomy to secure the patient’s airway. After tracheostomy we continued with endaural approach technique to remove the tumor, the origin of lesion was identified within the postcricoid area. Lesion was removed safely, sent to histology with no complication after. Results came back as a lipoma pedunculated. Literature search did not reveal any cases of limb lipoma presenting with a sudden hanging tumor causing airway compromise and dysphagia, all cases were diagnosed during routine examination. Our case has proven that hypopharyngoesophageal lipoma can present as an acute condition and we have to be able to save and manage patients like this.","PeriodicalId":50891,"journal":{"name":"Acta Medica Mediterranea","volume":"59 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75765534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Factors Related to the 6 Minute Walk Test: The Experience of a Referral Lung Transplantation Center 与6分钟步行测试相关的因素:转诊肺移植中心的经验
IF 0.3 4区 医学 Q4 Medicine Pub Date : 2022-03-17 DOI: 10.32552/2022.actamedica.692
Pınar Atagün Güney
Objectives: The 6-minute-walk test is a practical and widely used test, which indicates the exercise capacity in patients with a severe pulmonary disease. The study aims to investigate the related factors with the 6-minute-walk test in lung transplantation candidates. Materials and Method: The data were collected retrospectively from 349 patients, between January 2012 and September 2020. The patients were grouped according to their underlying lung disease as obstructive lung diseases, interstitial lung diseases, and infective lung diseases. The data collected included patient demographics, gender, body mass index, artery blood gas, the results of the respiratory function test, six-minute walk test, long-term oxygen therapy, and the need for non-invasive mechanical ventilation [such as group 1 (6MWD<200) and group 2(6MWD≥200)]. All of the collected data were analyzed and compared between the groups. Results: Overall, 349 patients were included in the study, and there were 123 females and 226 males (35.2% and 64.8% respectively) with a mean age of 46.92 ± 14.1 years. Their mean body mass index was 23.58 ± 12.52 kg/m2, the median FEV1(%) was 35.3 (33.4-37.2), the median six-minute walk distance was 222 m (125-335 m), and the mean PaO2/FiO2 (P/F) was 250.32% ± 74.81, the mean PCO2 was 45.71 mmHg ± 11.97. Furthermore, the patients using long-term oxygen therapy were (n=274, 78.5%) and non-invasive mechanical ventilation were (n=125, 35.8%). The mortality status, P/F, long-term oxygen therapy usage, and non-invasive mechanical ventilation usage were different between Group 1 and Group 2 (p=0.001, p=0.001, p<0.001, and p<0.001, respectively). There was no difference between the groups in patients with and without IPF between underlying diseases. The 6-minute walk test was found to have moderate correlation with FEV1 and P/F; and a negative correlation with age and PCO2 (p<0.01, r=0.33.8, p<0.001, r= 38.1 and p=0.17, r=12,7, p<0.001, r=-0.30.6, respectively). There was no correlation between P/F, FEV1, and body mass index; and also, between PCO2, age, and body mass index. Age had a weak correlation with FEV1(p<0.001, r=19.3). There was no correlation between the age and 6MWD, as well as P/F, PCO2, and the body mass index. The factors affecting survival in multivariate analysis were investigated by using the Cox regression model. It was observed that gender (OR, 0.001; 95% CI, 0.246-0.716; p=0.42), FEV1(OR, 1.02; 95% CI, 1.00-1.04; p<0.001), P/F (OR, 1.00; 95% CI, 1.00-1.01; p<0.001), and LTOT (OR, 9.83; 95% CI, 3.70-26.14; p<0.001) were independent factors associated with 6MWD<200 m. Conclusion: The 6-minute walk test is associated with mortality, gender, poor oxygenation, and with the utilization of domiciliary non-invasive mechanical ventilation or long-term oxygen therapy. Furthermore, it is an independent risk factor for mortality in lung transplant candidates and in providing a valuable method for the management of patients.
目的:6分钟步行测试是一项实用且应用广泛的测试,可以反映严重肺部疾病患者的运动能力。本研究旨在探讨肺移植候选者6分钟步行试验的相关因素。材料与方法:回顾性收集2012年1月至2020年9月期间349例患者的数据。患者根据其肺部基础疾病分为阻塞性肺病、间质性肺病和感染性肺病。收集的数据包括患者人口统计学、性别、体重指数、动脉血气、呼吸功能测试结果、6分钟步行测试、长期氧疗、有无需要无创机械通气[如1组(6MWD<200)和2组(6MWD≥200)]。对收集到的所有数据进行分析和组间比较。结果:共纳入349例患者,其中女性123例,男性226例(分别占35.2%和64.8%),平均年龄46.92±14.1岁。平均体重指数为23.58±12.52 kg/m2,平均FEV1(%)为35.3(33.4-37.2),平均6分钟步行距离为222 m (125-335 m),平均PaO2/FiO2 (P/F)为250.32%±74.81,平均PCO2为45.71 mmHg±11.97。长期氧疗患者274例(78.5%),无创机械通气患者125例(35.8%)。两组患者的死亡率、P/F、长期吸氧使用情况、无创机械通气使用情况差异有统计学意义(P =0.001、P =0.001、P <0.001、P <0.001)。有和没有IPF的两组患者在基础疾病之间没有差异。6分钟步行试验与FEV1和P/F有中等相关性;与年龄、PCO2呈负相关(p<0.01, r=0.33.8, p<0.001, r= 38.1, p=0.17, r=12,7, p<0.001, r=-0.30.6)。P/F、FEV1与体重指数无相关性;以及二氧化碳分压、年龄和体重指数之间的关系。年龄与FEV1的相关性较弱(p<0.001, r=19.3)。年龄与6MWD、P/F、PCO2和体重指数之间没有相关性。多因素分析中影响生存率的因素采用Cox回归模型。观察到性别(OR, 0.001;95% ci, 0.246-0.716;p=0.42), FEV1(OR, 1.02;95% ci, 1.00-1.04;p<0.001), p /F (OR, 1.00;95% ci, 1.00-1.01;p<0.001), LTOT (OR, 9.83;95% ci, 3.70-26.14;p<0.001)是6MWD<200 m的独立因素。结论:6分钟步行试验与死亡率、性别、氧合不良以及家庭无创机械通气或长期氧疗的使用有关。此外,它是肺移植候选人死亡率的独立危险因素,并为患者的管理提供了有价值的方法。
{"title":"The Factors Related to the 6 Minute Walk Test: The Experience of a Referral Lung Transplantation Center","authors":"Pınar Atagün Güney","doi":"10.32552/2022.actamedica.692","DOIUrl":"https://doi.org/10.32552/2022.actamedica.692","url":null,"abstract":"Objectives: The 6-minute-walk test is a practical and widely used test, which indicates the exercise capacity in patients with a severe pulmonary disease. The study aims to investigate the related factors with the 6-minute-walk test in lung transplantation candidates. \u0000Materials and Method: The data were collected retrospectively from 349 patients, between January 2012 and September 2020. The patients were grouped according to their underlying lung disease as obstructive lung diseases, interstitial lung diseases, and infective lung diseases. The data collected included patient demographics, gender, body mass index, artery blood gas, the results of the respiratory function test, six-minute walk test, long-term oxygen therapy, and the need for non-invasive mechanical ventilation [such as group 1 (6MWD<200) and group 2(6MWD≥200)]. All of the collected data were analyzed and compared between the groups. \u0000Results: Overall, 349 patients were included in the study, and there were 123 females and 226 males (35.2% and 64.8% respectively) with a mean age of 46.92 ± 14.1 years. Their mean body mass index was 23.58 ± 12.52 kg/m2, the median FEV1(%) was 35.3 (33.4-37.2), the median six-minute walk distance was 222 m (125-335 m), and the mean PaO2/FiO2 (P/F) was 250.32% ± 74.81, the mean PCO2 was 45.71 mmHg ± 11.97. Furthermore, the patients using long-term oxygen therapy were (n=274, 78.5%) and non-invasive mechanical ventilation were (n=125, 35.8%). The mortality status, P/F, long-term oxygen therapy usage, and non-invasive mechanical ventilation usage were different between Group 1 and Group 2 (p=0.001, p=0.001, p<0.001, and p<0.001, respectively). There was no difference between the groups in patients with and without IPF between underlying diseases. The 6-minute walk test was found to have moderate correlation with FEV1 and P/F; and a negative correlation with age and PCO2 (p<0.01, r=0.33.8, p<0.001, r= 38.1 and p=0.17, r=12,7, p<0.001, r=-0.30.6, respectively). There was no correlation between P/F, FEV1, and body mass index; and also, between PCO2, age, and body mass index. Age had a weak correlation with FEV1(p<0.001, r=19.3). There was no correlation between the age and 6MWD, as well as P/F, PCO2, and the body mass index. The factors affecting survival in multivariate analysis were investigated by using the Cox regression model. It was observed that gender (OR, 0.001; 95% CI, 0.246-0.716; p=0.42), FEV1(OR, 1.02; 95% CI, 1.00-1.04; p<0.001), P/F (OR, 1.00; 95% CI, 1.00-1.01; p<0.001), and LTOT (OR, 9.83; 95% CI, 3.70-26.14; p<0.001) were independent factors associated with 6MWD<200 m. \u0000Conclusion: The 6-minute walk test is associated with mortality, gender, poor oxygenation, and with the utilization of domiciliary non-invasive mechanical ventilation or long-term oxygen therapy. Furthermore, it is an independent risk factor for mortality in lung transplant candidates and in providing a valuable method for the management of patients.","PeriodicalId":50891,"journal":{"name":"Acta Medica Mediterranea","volume":"43 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74469991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Favipiravir to Hydroxychloroquine Plus Azithromycin in the Treatment of Patients with Non-critical COVID-19: A Single-center, Retrospective, Propensity Score-matched Study 法匹拉韦与羟氯喹加阿奇霉素治疗非危重型COVID-19患者的比较:一项单中心、回顾性、倾向评分匹配的研究
IF 0.3 4区 医学 Q4 Medicine Pub Date : 2022-03-17 DOI: 10.32552/2022.actamedica.719
O. A. Uyaroğlu, M. Ç. Sönmezer, G. Telli Dizman, Nursel Çalık Başaran, S. Karahan, Ö. Uzun
Objectives: In this study, we compared the clinical outcomes and effects of the treatments on laboratory parameters between patients who were treated with favipiravir (FAV) or hydroxychloroquine plus azithromycin (HCQ/AZ) for COVID-19 pneumonia in non-Intensive Care Unit (non-ICU) patients. Methods: We collected data of 260 moderate or severe COVID-19 patients hospitalized in COVID-19 wards between March 20, 2020, and September 30, 2020 retrospectively. We used propensity score matching to evaluate treatment effect on laboratory parameters of COVID-19 infection. Results: We compared 42 patients using FAV and 42 HCQ/AZ after propensity score matching. While there were statistical differences between the therapy groups in terms of transfer to ICU and/or exitus before matching (p=0.031), this was not significant after propensity analysis (p=0.250). Patients treated with FAV stayed in the hospital nearly one more day than HCQ/AZ group but the difference was not statistically significant (9.02 days vs 8.14 days, p=0.903). The levels of AST,ALT, and LDH increased at discharge in both groups, especially in the FAV group. Conclusions: FAV is not superior to HCQ/AZ in the treatment of COVID-19 infection in hospitalized patients with pneumonia.
目的:比较favipiravir (FAV)与羟氯喹+阿奇霉素(HCQ/AZ)治疗COVID-19肺炎非重症监护病房(非icu)患者的临床结局及治疗对实验室参数的影响。方法:回顾性收集2020年3月20日至2020年9月30日在COVID-19病房住院的260例中、重度COVID-19患者的资料。采用倾向评分匹配法评价治疗对COVID-19感染实验室参数的影响。结果:在倾向评分匹配后,我们比较了42例FAV患者和42例HCQ/AZ患者。虽然在配对前转入ICU和/或退出治疗组之间存在统计学差异(p=0.031),但经倾向分析后,这一差异无统计学意义(p=0.250)。FAV患者比HCQ/AZ组多住院近1天,但差异无统计学意义(9.02天vs 8.14天,p=0.903)。两组在放电时AST、ALT和LDH水平均升高,其中FAV组的升高幅度最大。结论:FAV治疗肺炎住院患者COVID-19感染的效果不优于HCQ/AZ。
{"title":"Comparison of Favipiravir to Hydroxychloroquine Plus Azithromycin in the Treatment of Patients with Non-critical COVID-19: A Single-center, Retrospective, Propensity Score-matched Study","authors":"O. A. Uyaroğlu, M. Ç. Sönmezer, G. Telli Dizman, Nursel Çalık Başaran, S. Karahan, Ö. Uzun","doi":"10.32552/2022.actamedica.719","DOIUrl":"https://doi.org/10.32552/2022.actamedica.719","url":null,"abstract":"Objectives: In this study, we compared the clinical outcomes and effects of the treatments on laboratory parameters between patients who were treated with favipiravir (FAV) or hydroxychloroquine plus azithromycin (HCQ/AZ) for COVID-19 pneumonia in non-Intensive Care Unit (non-ICU) patients. \u0000Methods: We collected data of 260 moderate or severe COVID-19 patients hospitalized in COVID-19 wards between March 20, 2020, and September 30, 2020 retrospectively. We used propensity score matching to evaluate treatment effect on laboratory parameters of COVID-19 infection. \u0000Results: We compared 42 patients using FAV and 42 HCQ/AZ after propensity score matching. While there were statistical differences between the therapy groups in terms of transfer to ICU and/or exitus before matching (p=0.031), this was not significant after propensity analysis (p=0.250). Patients treated with FAV stayed in the hospital nearly one more day than HCQ/AZ group but the difference was not statistically significant (9.02 days vs 8.14 days, p=0.903). The levels of AST,ALT, and LDH increased at discharge in both groups, especially in the FAV group. \u0000Conclusions: FAV is not superior to HCQ/AZ in the treatment of COVID-19 infection in hospitalized patients with pneumonia.","PeriodicalId":50891,"journal":{"name":"Acta Medica Mediterranea","volume":"23 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90085146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Different Therapeutic Modalities on Demodex Densities and Clinical Symptoms of Patients with Demodicosis 不同治疗方式对蠕形螨密度及蠕形螨病患者临床症状的影响
IF 0.3 4区 医学 Q4 Medicine Pub Date : 2022-03-17 DOI: 10.32552/2022.actamedica.721
Başak Yalıcı Armağan, N. Atakan
Background: Demodicosis represents cutaneous diseases caused by cutaneous overpopulation of Demodex mites. The aim of this study was to evaluate the effect of different treatment options on Demodex densities (Dds) and clinical symptoms of patients with demodicosis. Methods: Patients with high Dds in two consecutive standardized skin surface biopsies (SSSB1>5 D/cm2 or SSSB2>10 D/cm²) and concomitant clinical symptoms were evaluated retrospectively. Measurements of treatment effectiveness included clinical improvement and normalization or reducing of Dds. Results: A total of 21 patients included in the study. Five patients received topical permethrin and crotamiton whereas 16 patients received systemic metronidazole in combination with topical permethrin and/or crotamiton. The treatment was continued with topical ivermectin in 2 patients who had failure with other treatments. The median treatment duration was 3 months (IQR 1-4). Pre- and post-treatment median Dds decreased 30 to 14 D/cm2 on SSSB1 whereas 81 to 80 D/cm2 on SSSB2, respectively. There was no statistically significant decrease in Dds on SSSB1 and SSSB2 after the treatment (p=0.173 and p=0.134, respectively). Clinical improvement was recorded in a total of 14 patients (66.6%) of whom only 2 patients (9.5%) had normalization on Dds. Additionally, topical ivermectin provided a rapid clinical improvement and normalization on Dds in both 2 patients. Conclusion: Irrespective of the treatment, more than two-thirds of the patients improved clinically without a significant change in Dds. This finding may suggest that the treatment response has been mostly associated with the anti-inflammatory properties of the agents. Topical ivermectin seems to be a more suitable treatment option for demodicosis with positive effects on both clinical findings and Dds.
背景:蠕形螨病是由皮肤蠕形螨种群过多引起的皮肤病。本研究的目的是评估不同治疗方案对蠕形螨密度(Dds)和蠕形螨病患者临床症状的影响。方法:回顾性评价连续两次标准化皮肤表面活检dd值较高(SSSB1>5 D/cm2或SSSB2>10 D/cm2)及伴随临床症状的患者。治疗效果的测量包括临床改善和Dds的正常化或降低。结果:共纳入21例患者。5例患者接受局部氯菊酯和克罗米坦治疗,16例患者接受全身甲硝唑联合局部氯菊酯和克罗米坦治疗。在其他治疗失败的2例患者中继续使用局部伊维菌素治疗。中位治疗时间为3个月(IQR 1-4)。SSSB1处理前和处理后的中位Dds降低了30 ~ 14 D/cm2,而SSSB2处理后的中位Dds分别降低了81 ~ 80 D/cm2。治疗后SSSB1和SSSB2的Dds降低无统计学意义(p=0.173和p=0.134)。14例(66.6%)患者临床改善,其中2例(9.5%)患者Dds恢复正常。此外,局部伊维菌素使两例患者的Dds迅速改善和正常化。结论:无论采用何种治疗方法,超过三分之二的患者在临床上得到改善,但Dds没有显著变化。这一发现可能表明,治疗反应主要与药物的抗炎特性有关。局部伊维菌素似乎是一种更合适的治疗选择,对临床表现和Dds都有积极的影响。
{"title":"The Effect of Different Therapeutic Modalities on Demodex Densities and Clinical Symptoms of Patients with Demodicosis","authors":"Başak Yalıcı Armağan, N. Atakan","doi":"10.32552/2022.actamedica.721","DOIUrl":"https://doi.org/10.32552/2022.actamedica.721","url":null,"abstract":"Background: Demodicosis represents cutaneous diseases caused by cutaneous overpopulation of Demodex mites. The aim of this study was to evaluate the effect of different treatment options on Demodex densities (Dds) and clinical symptoms of patients with demodicosis. \u0000Methods: Patients with high Dds in two consecutive standardized skin surface biopsies (SSSB1>5 D/cm2 or SSSB2>10 D/cm²) and concomitant clinical symptoms were evaluated retrospectively. Measurements of treatment effectiveness included clinical improvement and normalization or reducing of Dds. \u0000Results: A total of 21 patients included in the study. Five patients received topical permethrin and crotamiton whereas 16 patients received systemic metronidazole in combination with topical permethrin and/or crotamiton. The treatment was continued with topical ivermectin in 2 patients who had failure with other treatments. The median treatment duration was 3 months (IQR 1-4). Pre- and post-treatment median Dds decreased 30 to 14 D/cm2 on SSSB1 whereas 81 to 80 D/cm2 on SSSB2, respectively. There was no statistically significant decrease in Dds on SSSB1 and SSSB2 after the treatment (p=0.173 and p=0.134, respectively). Clinical improvement was recorded in a total of 14 patients (66.6%) of whom only 2 patients (9.5%) had normalization on Dds. Additionally, topical ivermectin provided a rapid clinical improvement and normalization on Dds in both 2 patients. \u0000Conclusion: Irrespective of the treatment, more than two-thirds of the patients improved clinically without a significant change in Dds. This finding may suggest that the treatment response has been mostly associated with the anti-inflammatory properties of the agents. Topical ivermectin seems to be a more suitable treatment option for demodicosis with positive effects on both clinical findings and Dds.","PeriodicalId":50891,"journal":{"name":"Acta Medica Mediterranea","volume":"2 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90446076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Distribution of Intestinal Parasites Detected in Ankara Training and Research Hospital between 2017 and 2020 2017年至2020年在安卡拉培训和研究医院检测到的肠道寄生虫分布
IF 0.3 4区 医学 Q4 Medicine Pub Date : 2022-03-17 DOI: 10.32552/2022.actamedica.715
Filiz Kaya, M. Kocaağa
Objective: The aim of this study was to evaluate the current prevalence of intestinal parasites in patients admitted to Ankara Training and Research Hospital during the period of 2017 to 2020. Materials and Methods: Intestinal parasitic examination results of patients between 2017 and 2020 were evaluated retrospectively. Data on demographic and clinical parameters were obtained from the laboratory information management system. Results: E. vermicularis eggs were found in 7.2% of 2348 samples examined by cellophane tape method. One or more intestinal parasites were detected in 18.2% of 4211 samples examined stool concentration method. Intestinal parasite positivity was the highest in children aged 6-18 years among age groups. The most frequently detected intestinal parasites were Blastocystis sp., E. vermicularis, Dientamoeba fragilis and Giardia intestinalis. Conclusion: Although our hospital is in the center of Ankara Training and Research Hospital, it mostly serves patients with low socioeconomic status and immigrant individuals; therefore total intestinal parasite detection rate was found relatively high. Intestinal parasitic infections are still an important public health issue in our country. It is important to determine the prevalence of parasitic infections to develop optimal prevention and treatment strategies.
目的:本研究旨在评估2017年至2020年安卡拉培训与研究医院住院患者肠道寄生虫的流行情况。材料与方法:回顾性分析2017 ~ 2020年患者肠道寄生虫检查结果。人口学和临床参数数据从实验室信息管理系统获取。结果:玻璃纸法检出的2348份样品中,有7.2%检出蛭卵。4211份粪便标本中检出一种或多种肠道寄生虫,占18.2%。肠道寄生虫阳性率以6 ~ 18岁儿童最高。检出最多的肠道寄生虫为囊虫、蠕虫、脆弱地阿米巴和肠贾第虫。结论:我院虽位于安卡拉培训与研究医院中心,但主要服务于社会经济地位低的患者和移民个体;因此发现总肠道寄生虫检出率较高。肠道寄生虫感染仍然是我国一个重要的公共卫生问题。确定寄生虫感染的流行情况对于制定最佳的预防和治疗策略具有重要意义。
{"title":"Distribution of Intestinal Parasites Detected in Ankara Training and Research Hospital between 2017 and 2020","authors":"Filiz Kaya, M. Kocaağa","doi":"10.32552/2022.actamedica.715","DOIUrl":"https://doi.org/10.32552/2022.actamedica.715","url":null,"abstract":"Objective: The aim of this study was to evaluate the current prevalence of intestinal parasites in patients admitted to Ankara Training and Research Hospital during the period of 2017 to 2020. \u0000Materials and Methods: Intestinal parasitic examination results of patients between 2017 and 2020 were evaluated retrospectively. Data on demographic and clinical parameters were obtained from the laboratory information management system. \u0000Results: E. vermicularis eggs were found in 7.2% of 2348 samples examined by cellophane tape method. One or more intestinal parasites were detected in 18.2% of 4211 samples examined stool concentration method. Intestinal parasite positivity was the highest in children aged 6-18 years among age groups. The most frequently detected intestinal parasites were Blastocystis sp., E. vermicularis, Dientamoeba fragilis and Giardia intestinalis. \u0000Conclusion: Although our hospital is in the center of Ankara Training and Research Hospital, it mostly serves patients with low socioeconomic status and immigrant individuals; therefore total intestinal parasite detection rate was found relatively high. Intestinal parasitic infections are still an important public health issue in our country. It is important to determine the prevalence of parasitic infections to develop optimal prevention and treatment strategies.","PeriodicalId":50891,"journal":{"name":"Acta Medica Mediterranea","volume":"102 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73220903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Medica Mediterranea
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1